CIK 1643354
Lion Point Capital, LP
Institutional 13F holdings & portfolio
Holdings
39
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–39 of 39
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| MIST | MILESTONE PHARMACEUTICALS IN | 755K | $1M+ | SH |
| PRAX | PRAXIS PRECISION MEDICINES I | 4K | $1M+ | SH |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 68K | $500K+ | SH |
| FENC | FENNEC PHARMACEUTICALS INC | 112K | $500K+ | SH |
| JSPR | JASPER THERAPEUTICS INC | 465K | $500K+ | SH |
| BNTC | BENITEC BIOPHARMA INC | 62K | $500K+ | SH |
| RPRX | ROYALTY PHARMA PLC | 21K | $500K+ | SH |
| GERN | GERON CORP | 578K | $500K+ | SH |
| SNDX | SYNDAX PHARMACEUTICALS INC | 36K | $500K+ | SH |
| ARDX | ARDELYX INC | 129K | $500K+ | SH |
| CUE | CUE BIOPHARMA INC | 2.2M | $500K+ | SH |
| IRON | DISC MEDICINE INC | 8K | $500K+ | SH |
| SRPT | SAREPTA THERAPEUTICS INC | 29K | $500K+ | SH |
| BHVN | BIOHAVEN LTD | 52K | $500K+ | SH |
| HUMA | HUMACYTE INC | 500K | $100K–$500K | SH |
| KURA | KURA ONCOLOGY INC | 46K | $100K–$500K | SH |
| MCRB | SERES THERAPEUTICS INC | 32K | $100K–$500K | SH |
| CMPS | COMPASS PATHWAYS PLC | 58K | $100K–$500K | SH |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 42K | $100K–$500K | SH |
| RGNX | REGENXBIO INC | 27K | $100K–$500K | SH |
| BBIO | BRIDGEBIO PHARMA INC | 5K | $100K–$500K | SH |
| MLYS | MINERALYS THERAPEUTICS INC | 11K | $100K–$500K | SH |
| VTYX | VENTYX BIOSCIENCES INC | 42K | $100K–$500K | SH |
| LNTH | LANTHEUS HLDGS INC | 6K | $100K–$500K | SH |
| DYN | DYNE THERAPEUTICS INC | 18K | $100K–$500K | SH |
| QURE | UNIQURE NV | 15K | $100K–$500K | SH |
| PCRX | PACIRA PHARMACEUTICALS INC | 14K | $100K–$500K | SH |
| VTRS | VIATRIS INC | 28K | $100K–$500K | SH |
| AZTA | AZENTA INC | 10K | $100K–$500K | SH |
| RCKT | ROCKET PHARMACEUTICALS INC | 86K | $100K–$500K | SH |
| JANX | JANUX THERAPEUTICS INC | 19K | $100K–$500K | SH |
| EWTX | EDGEWISE THERAPEUTICS INC | 9K | $100K–$500K | SH |
| INVA | INNOVIVA INC | 8K | $100K–$500K | SH |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 5K | $100K–$500K | SH |
| IPHA | INNATE PHARMA S A | 81K | $100K–$500K | SH |
| NERV | MINERVA NEUROSCIENCES INC | 35K | $100K–$500K | SH |
| GHRS | GH RESEARCH PLC | 10K | $100K–$500K | SH |
| SPRB | SPRUCE BIOSCIENCES INC | 1K | $50K–$100K | SH |
| MRSN | MERSANA THERAPEUTICS INC | 100 | $1K–$15K | SH |